{"schema_version":"secwatch.filing_event.v1","accession":"0000875320-24-000207","form_type":"8-K","ticker":"VRTX","cik":"0000875320","company_name":"VERTEX PHARMACEUTICALS INC / MA","filed_at":"2024-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.111537+00:00","generated_at":"2026-05-31T08:55:35.222359+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Vertex extends Boston headquarters leases to 2044, adding renewal options","bullets":["Extended combined ~1.1 million sq ft of office and lab space under two leases in Boston.","Lease term extended from December 2028 to June 30, 2044, with options for two additional ten-year periods.","Amendments signed with SNH Seaport LLC on August 15, 2024.","Previous lease had a single 10-year extension option; new terms provide up to 20 additional years."],"urls":{"canonical":"https://secwatch.observer/filing/0000875320-24-000207","json":"https://secwatch.observer/filing/0000875320-24-000207.json","markdown":"https://secwatch.observer/filing/0000875320-24-000207.md","text":"https://secwatch.observer/filing/0000875320-24-000207.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000207/0000875320-24-000207-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000207/vrtx-20240815.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:55:35.222359+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}